US4479795A
(en)
*
|
1979-06-29 |
1984-10-30 |
The Procter & Gamble Company |
Antimicrobial polymer compositions
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US5366738A
(en)
*
|
1982-07-29 |
1994-11-22 |
Merck & Co., Inc. |
Controlled release drug dispersion delivery device
|
US4466705A
(en)
*
|
1982-09-30 |
1984-08-21 |
Michelson Paul E |
Fluid lens
|
US4709996A
(en)
*
|
1982-09-30 |
1987-12-01 |
Michelson Paul E |
Fluid lens
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
GB8305797D0
(en)
*
|
1983-03-02 |
1983-04-07 |
Graham N B |
Hydrogel-containing envelopes
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
NZ206600A
(en)
*
|
1983-05-11 |
1987-01-23 |
Alza Corp |
Osmotic drug delivery device
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
AT394944B
(de)
*
|
1983-05-11 |
1992-07-27 |
Alza Corp |
Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
AU591171B2
(en)
*
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4781714A
(en)
*
|
1983-11-02 |
1988-11-01 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4595583A
(en)
*
|
1984-03-19 |
1986-06-17 |
Alza Corporation |
Delivery system controlled administration of beneficial agent to ruminants
|
US4927633A
(en)
*
|
1984-03-19 |
1990-05-22 |
Alza Corporation |
Dispenser for delivering drug to livestock
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4717566A
(en)
*
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4624945A
(en)
*
|
1984-03-19 |
1986-11-25 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4772474A
(en)
*
|
1985-08-09 |
1988-09-20 |
Alza Corporation |
Dispenser with internal arrangement of lamina means for dispensing beneficial agent
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
GB2155889B
(en)
*
|
1984-03-21 |
1988-03-02 |
Alza Corp |
Dispenser-capsule
|
US4678467A
(en)
*
|
1984-03-21 |
1987-07-07 |
Alza Corporation |
Dispenser comprising capsule with volume displacing member
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4627971A
(en)
*
|
1985-04-22 |
1986-12-09 |
Alza Corporation |
Osmotic device with self-sealing passageway
|
US4624847A
(en)
*
|
1985-04-22 |
1986-11-25 |
Alza Corporation |
Drug delivery device for programmed delivery of beneficial drug
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4717718A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Device for the controlled delivery of a beneficial agent
|
US4717568A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Laminar arrangement for increasing delivery of beneficial agent from dispenser
|
US4963141A
(en)
*
|
1985-08-16 |
1990-10-16 |
Alza Corporation |
Dispensing system for administering beneficial agent formulation to ruminants
|
US4955881A
(en)
*
|
1985-08-16 |
1990-09-11 |
Alza Corporation |
Ruminant dispensing device
|
US4643731A
(en)
*
|
1985-08-16 |
1987-02-17 |
Alza Corporation |
Means for providing instant agent from agent dispensing system
|
US4865598A
(en)
*
|
1985-08-16 |
1989-09-12 |
Alza Corporation |
Dispensing system for administering beneficial agent
|
US4966767A
(en)
*
|
1985-08-16 |
1990-10-30 |
Alza Corporation |
Ruminant dispensing device comprising agent displacement member
|
US4883667A
(en)
*
|
1985-08-16 |
1989-11-28 |
Alza Corporation |
Process for forming dispensing device
|
US4704118A
(en)
*
|
1985-08-16 |
1987-11-03 |
Alza Corporation |
Ruminant dispensing device with thermo-activated memory
|
US4871544A
(en)
*
|
1985-08-16 |
1989-10-03 |
Alza Corporation |
Ruminant dispensing device
|
US5098425A
(en)
*
|
1985-08-16 |
1992-03-24 |
Alza Corporation |
Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
|
US5008288A
(en)
*
|
1986-01-06 |
1991-04-16 |
Alfred Stracher |
Carnitine directed pharmaceutical agents
|
US4866040A
(en)
*
|
1986-01-06 |
1989-09-12 |
Alfred Stracher |
Aminocarnitine directed pharmaceutical agents
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4723957A
(en)
*
|
1986-02-07 |
1988-02-09 |
Alza Corp. |
System for delivering drug with enhanced bioacceptability
|
US4865845A
(en)
*
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
US4863456A
(en)
*
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
GB2189702B
(en)
*
|
1986-04-30 |
1989-10-18 |
Alza Corp |
Dosage form with improved delivery capability
|
US4960416A
(en)
*
|
1986-04-30 |
1990-10-02 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
US4983400A
(en)
*
|
1986-06-16 |
1991-01-08 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
US4755180A
(en)
*
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
CH668187A5
(de)
*
|
1986-08-07 |
1988-12-15 |
Ciba Geigy Ag |
Therapeutisches system mit systemischer wirkung.
|
USRE34990E
(en)
*
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
ATE72111T1
(de)
*
|
1987-01-14 |
1992-02-15 |
Ciba Geigy Ag |
Therapeutisches system fuer schwerloesliche wirkstoffe.
|
JPS63180224A
(ja)
*
|
1987-01-21 |
1988-07-25 |
Matsushita Electric Ind Co Ltd |
無線機のアンテナ回路
|
US4940465A
(en)
*
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US4892778A
(en)
*
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US4876093A
(en)
*
|
1987-07-02 |
1989-10-24 |
Alza Corporation |
Dispenser with dispersing member for delivering beneficial agent
|
US4824675A
(en)
*
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4915949A
(en)
*
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4891223A
(en)
*
|
1987-09-03 |
1990-01-02 |
Air Products And Chemicals, Inc. |
Controlled release delivery coating formulation for bioactive substances
|
US4950486A
(en)
*
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4946687A
(en)
*
|
1987-10-02 |
1990-08-07 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4816263A
(en)
*
|
1987-10-02 |
1989-03-28 |
Alza Corporation |
Dosage form for treating cardiovascular diseases comprising isradipine
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5030456A
(en)
*
|
1988-11-07 |
1991-07-09 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US5376383A
(en)
*
|
1988-11-21 |
1994-12-27 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma-cholesterol levels
|
US4997658A
(en)
*
|
1988-11-21 |
1991-03-05 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma cholesterol levels
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
DD295760A5
(de)
*
|
1989-01-31 |
1991-11-14 |
Martin-Luther-Universitaet Halle Wittenberg,De |
Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
|
FI900470A0
(fi)
*
|
1989-01-31 |
1990-01-30 |
Int Pharma Agentur |
Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
|
US6200600B1
(en)
*
|
1989-02-16 |
2001-03-13 |
Btg International Limited |
Controlled delay release device
|
US5181505A
(en)
*
|
1989-03-08 |
1993-01-26 |
Lew Chel W |
Method and apparatus for delivery of a medicament in the oral cavity
|
US5002540A
(en)
*
|
1989-05-22 |
1991-03-26 |
Warren Kirschbaum |
Intravaginal device and method for delivering a medicament
|
US5776493A
(en)
*
|
1989-07-14 |
1998-07-07 |
Alza Corporation |
Oral osmotic device for delivery of nystatin with hydrogel driving member
|
US5021053A
(en)
*
|
1989-07-14 |
1991-06-04 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5030216A
(en)
*
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5660851A
(en)
*
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5057321A
(en)
*
|
1990-06-13 |
1991-10-15 |
Alza Corporation |
Dosage form comprising drug and maltodextrin
|
US5128145A
(en)
*
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
NZ238867A
(en)
*
|
1990-07-12 |
1993-08-26 |
Alza Corp |
Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
|
US5147654A
(en)
*
|
1990-07-23 |
1992-09-15 |
Alza Corporation |
Oral osmotic device for delivering nicotine
|
WO1992005775A1
(en)
*
|
1990-09-28 |
1992-04-16 |
Pfizer Inc. |
Dispensing device containing a hydrophobic medium
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5593852A
(en)
|
1993-12-02 |
1997-01-14 |
Heller; Adam |
Subcutaneous glucose electrode
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5208037A
(en)
*
|
1991-04-22 |
1993-05-04 |
Alza Corporation |
Dosage forms comprising polymers comprising different molecular weights
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US5190765A
(en)
*
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5252338A
(en)
*
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
JPH07500264A
(ja)
*
|
1991-10-10 |
1995-01-12 |
アルザ・コーポレーション |
疎水性壁材料による浸透圧薬物投与デバイス
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
US5543154A
(en)
*
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5248310A
(en)
*
|
1992-03-27 |
1993-09-28 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5512299A
(en)
*
|
1992-03-30 |
1996-04-30 |
Alza Corporation |
Method of treating oral inflammatory disease
|
US5869097A
(en)
*
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
US5573776A
(en)
*
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
HU213407B
(en)
*
|
1993-12-09 |
1997-06-30 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tablet with diffusive-osmotic release
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
GB9326267D0
(en)
*
|
1993-12-23 |
1994-02-23 |
Scherer Corp R P |
Expulsion of material
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5540665A
(en)
*
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US5460826A
(en)
*
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5529787A
(en)
*
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
IE70735B1
(en)
*
|
1994-08-15 |
1996-12-11 |
Elan Med Tech |
Orally administrable delivery device
|
US5837276A
(en)
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
US5582591A
(en)
*
|
1994-09-02 |
1996-12-10 |
Delab |
Delivery of solid drug compositions
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5614578A
(en)
*
|
1994-10-28 |
1997-03-25 |
Alza Corporation |
Injection-molded dosage form
|
US5582838A
(en)
*
|
1994-12-22 |
1996-12-10 |
Merck & Co., Inc. |
Controlled release drug suspension delivery device
|
US5534263A
(en)
*
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5876741A
(en)
*
|
1995-03-30 |
1999-03-02 |
Medlogic Global Corporation |
Chemo-mechanical expansion delivery system
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US6124355A
(en)
*
|
1995-05-22 |
2000-09-26 |
Guittard; George V. |
Oxybutynin therapy
|
US6262115B1
(en)
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5780058A
(en)
*
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
US5840332A
(en)
*
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
WO1997033566A2
(en)
*
|
1996-03-12 |
1997-09-18 |
Alza Corporation |
Composition and dosage form comprising opioid antagonist
|
ZA97976B
(en)
*
|
1996-04-05 |
1997-08-18 |
Alza Corp |
Uniform drug delivery theraphy.
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
CA2263558A1
(en)
*
|
1996-08-16 |
1998-02-19 |
Alza Corporation |
Dosage form for providing ascending dose of drug
|
AU729905B2
(en)
*
|
1996-10-18 |
2001-02-15 |
Alza Corporation |
Multiple flow path device for oral delivery of discrete units
|
DK0936894T3
(da)
|
1996-10-18 |
2001-11-19 |
Alza Corp |
Indretning til afgivelse af aktivt middel
|
US6024721A
(en)
*
|
1996-10-18 |
2000-02-15 |
Alza Corporation |
Mixing system for an active agent delivery device
|
US6361796B1
(en)
*
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
AU721653B2
(en)
*
|
1996-10-25 |
2000-07-13 |
Supernus Pharmaceuticals, Inc. |
Soluble form osmotic dose delivery system
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
WO1998023263A1
(en)
*
|
1996-11-25 |
1998-06-04 |
Alza Corporation |
Ascending-dose dosage form
|
EP1782798A3
(de)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Darreichungsform mit ansteigender Dosisfreisetzung
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20030100532A1
(en)
*
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
JP3285366B2
(ja)
*
|
1997-05-16 |
2002-05-27 |
アルザ コーポレイション |
活性薬剤放出デバイス用の流動制御手段構造
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
AU9221898A
(en)
|
1997-09-09 |
1999-03-29 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
US7060734B1
(en)
|
1997-09-09 |
2006-06-13 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
DE69821520T2
(de)
|
1997-11-10 |
2004-12-16 |
G.D. Searle & Co., Chicago |
Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz
|
PT1035834E
(pt)
|
1997-12-05 |
2002-09-30 |
Alza Corp |
Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
DK1041975T3
(da)
|
1997-12-22 |
2002-11-04 |
Alza Corp |
Hastighedskontrollerende membraner til anordninger til kontrolleret indførsel af medikament
|
ATE331515T1
(de)
|
1998-02-12 |
2006-07-15 |
Searle Llc |
Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
US6134461A
(en)
|
1998-03-04 |
2000-10-17 |
E. Heller & Company |
Electrochemical analyte
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6365183B1
(en)
*
|
1998-05-07 |
2002-04-02 |
Alza Corporation |
Method of fabricating a banded prolonged release active agent dosage form
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US7890176B2
(en)
*
|
1998-07-06 |
2011-02-15 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating chronic pelvic pain
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
ID29632A
(id)
|
1998-07-24 |
2001-09-06 |
Seo Hong Yoo |
Pembuatan bentuk-bentuk dosis larutan bening berair dengan asam-asam empedu
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
NZ510020A
(en)
*
|
1998-09-09 |
2003-06-30 |
Alza Corp |
Membrane coated capsule for sustained release of a drug formulation, and a granulated composition, in liquid form
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6087396A
(en)
*
|
1998-10-05 |
2000-07-11 |
Situs Corporation |
Oxybutynin formulations and method of use
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
JP2002532406A
(ja)
|
1998-12-17 |
2002-10-02 |
アルザ・コーポレーション |
複合コーティングによる液体充填ゼラチンカプセルの放出制御システムへの変換
|
JP4864204B2
(ja)
|
1998-12-18 |
2012-02-01 |
アルザ・コーポレーション |
透明な経皮的ニコチン送達デバイス
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
EP1154691A4
(de)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae
|
ATE433318T1
(de)
*
|
1999-02-10 |
2009-06-15 |
Pfizer Prod Inc |
Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
DE60039729D1
(de)
*
|
1999-02-12 |
2008-09-11 |
United Therapeutics Corp |
N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
|
EP1173161A2
(de)
|
1999-02-12 |
2002-01-23 |
G.D. SEARLE & CO. |
Verwendung von glucamin derivaten zur behandlung von hepatitis infektionen
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US8545880B2
(en)
*
|
1999-02-26 |
2013-10-01 |
Andrx Pharmaceuticals, Llc |
Controlled release oral dosage form
|
US6210716B1
(en)
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217896B1
(en)
*
|
1999-04-01 |
2001-04-17 |
Uab Research Foundation |
Conjunctival inserts for topical delivery of medication or lubrication
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US6287870B1
(en)
*
|
1999-08-20 |
2001-09-11 |
Robert A. Levine |
Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
CO5210862A1
(es)
|
1999-09-15 |
2002-10-30 |
Alza Corp |
Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
|
US6387325B1
(en)
*
|
1999-10-08 |
2002-05-14 |
Becton Dickinson & Company |
Assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
DE60040876D1
(de)
|
1999-10-21 |
2009-01-02 |
Alcon Inc |
Medikamentenzuführeinrichtung
|
ES2240180T3
(es)
|
1999-10-21 |
2005-10-16 |
Alcon Inc. |
Administracion sub-tenon de medicamentos.
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
DZ3228A1
(fr)
*
|
1999-12-23 |
2001-07-05 |
Pfizer Prod Inc |
Médicament dérivé d'un hydrogel sous forme de pastille
|
BR0016707A
(pt)
|
1999-12-23 |
2002-09-03 |
Pfizer Prod Inc |
Forma de dosagem de droga em camadas acionada por hidrogel
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
CN100558407C
(zh)
*
|
2000-02-04 |
2009-11-11 |
柳署弘 |
制备含有胆汁酸的澄清水溶液剂型
|
JP2003522791A
(ja)
*
|
2000-02-14 |
2003-07-29 |
ファルマシア コーポレイション |
肝炎ウイルス感染症治療用n‐置換‐1,5‐ジデオキシ‐1,5‐イミノ‐d‐グルシトール化合物の使用
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
US6582441B1
(en)
|
2000-02-24 |
2003-06-24 |
Advanced Bionics Corporation |
Surgical insertion tool
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US7989436B2
(en)
*
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US6660726B2
(en)
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
AU2001257359A1
(en)
|
2000-04-27 |
2001-11-07 |
Verion Inc. |
Zero order release and temperature-controlled microcapsules and process for the preparation thereof
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
CA2429945A1
(en)
*
|
2000-11-29 |
2002-06-06 |
Durect Corporation |
Devices and methods for controlled delivery from a drug delivery device
|
CA2429998C
(en)
|
2000-11-29 |
2012-01-17 |
Oculex Pharmaceuticals, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US20060064140A1
(en)
*
|
2001-01-30 |
2006-03-23 |
Whitehurst Todd K |
Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
|
US7493172B2
(en)
*
|
2001-01-30 |
2009-02-17 |
Boston Scientific Neuromodulation Corp. |
Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
|
US20050143789A1
(en)
*
|
2001-01-30 |
2005-06-30 |
Whitehurst Todd K. |
Methods and systems for stimulating a peripheral nerve to treat chronic pain
|
IN190699B
(de)
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
CA2441064A1
(en)
*
|
2001-03-16 |
2002-09-26 |
Andrx Corporation |
Controlled release sulfonylurea formulation
|
US7041468B2
(en)
|
2001-04-02 |
2006-05-09 |
Therasense, Inc. |
Blood glucose tracking apparatus and methods
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
ATE506929T1
(de)
|
2001-06-12 |
2011-05-15 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
DE10129725A1
(de)
*
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US20040180087A1
(en)
*
|
2001-06-21 |
2004-09-16 |
Boyong Li |
Stable controlled release pharmaceutical compositions containing pravastatin
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
PT1409065E
(pt)
|
2001-07-23 |
2007-03-30 |
Alcon Inc |
Dispositivo de administração de fármacos oftálmicos
|
US20030091634A1
(en)
*
|
2001-09-14 |
2003-05-15 |
Pawan Seth |
Delayed release tablet of venlafaxin
|
JP2005509605A
(ja)
*
|
2001-09-28 |
2005-04-14 |
マクニール−ピーピーシー・インコーポレイテッド |
可食性組成物と可食性外皮を含む剤形
|
US20030153864A1
(en)
*
|
2001-10-16 |
2003-08-14 |
Bernard Chaffringeon |
Disposable device and method for transferring an active liquid into a body cavity
|
US8329217B2
(en)
*
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
US20030185882A1
(en)
*
|
2001-11-06 |
2003-10-02 |
Vergez Juan A. |
Pharmaceutical compositions containing oxybutynin
|
US7183321B2
(en)
*
|
2001-12-17 |
2007-02-27 |
Bristol-Myers Squibb Company |
Antidiabetic formulation and method
|
TW200302748A
(en)
*
|
2002-02-01 |
2003-08-16 |
Pfizer Prod Inc |
Osmotic delivery system
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US7613491B2
(en)
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
MXPA04009701A
(es)
*
|
2002-04-05 |
2005-05-27 |
Penwest Pharmaceuticals Co |
Formulaciones de metoprolol de liberacion sostenida.
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US6733526B2
(en)
|
2002-04-25 |
2004-05-11 |
Advanced Medical Optics, Inc. |
Method of improving adherence and centering of intra-corneal implants on corneal bed
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
DE60325715D1
(de)
*
|
2002-04-29 |
2009-02-26 |
Alza Corp |
Methoden und darreichungsformen zur kontrollierten freisetzung von oxykodon
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US7328706B2
(en)
|
2002-05-06 |
2008-02-12 |
Dynamic Mouth Devices Llc |
Therapeutic and protective dental device useful as an intra-oral delivery system
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7151961B1
(en)
*
|
2002-05-24 |
2006-12-19 |
Advanced Bionics Corporation |
Treatment of movement disorders by brain stimulation
|
RU2004134728A
(ru)
*
|
2002-05-31 |
2005-06-10 |
Алза Корпорейшн (Us) |
Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
|
US20040043067A1
(en)
*
|
2002-06-19 |
2004-03-04 |
Salamone Joseph C. |
Fluorosiloxane matrix controlled diffusion drug delivery systems
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
AU2003256848A1
(en)
*
|
2002-07-29 |
2004-02-16 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US7254449B2
(en)
*
|
2002-07-31 |
2007-08-07 |
Advanced Bionics Corp |
Systems and methods for providing power to one or more implantable devices
|
US20060009739A1
(en)
*
|
2002-09-06 |
2006-01-12 |
Durect Corporation |
Implantable flow regulator with failsafe mode and reserve drug supply
|
CA2497867A1
(en)
|
2002-09-06 |
2004-03-18 |
Durect Corporation |
Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
PT1551372T
(pt)
*
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
Subunidade de sequestração e composições e métodos relacionados
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
US20040091538A1
(en)
*
|
2002-10-31 |
2004-05-13 |
Crystal Pollock-Dove |
Dosage form providing ascending release of liquid formulation
|
US7381184B2
(en)
|
2002-11-05 |
2008-06-03 |
Abbott Diabetes Care Inc. |
Sensor inserter assembly
|
GB2395126A
(en)
*
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
CA2507522C
(en)
|
2002-12-13 |
2015-02-24 |
Durect Corporation |
Oral drug delivery system
|
US7811231B2
(en)
|
2002-12-31 |
2010-10-12 |
Abbott Diabetes Care Inc. |
Continuous glucose monitoring system and methods of use
|
US8771183B2
(en)
|
2004-02-17 |
2014-07-08 |
Abbott Diabetes Care Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US20050048099A1
(en)
*
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
US20040166160A1
(en)
*
|
2003-01-14 |
2004-08-26 |
Ramkumar Subramanian |
Methods and dosage forms with modified viscosity layers
|
JP3811127B2
(ja)
*
|
2003-01-30 |
2006-08-16 |
株式会社東芝 |
情報記録装置及び情報記録方法
|
DE602004015246D1
(de)
*
|
2003-02-11 |
2008-09-04 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
CA2521471A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Barr Laboratories, Inc. |
Methods of administering estrogens and progestins
|
US20040213850A1
(en)
*
|
2003-04-25 |
2004-10-28 |
Eleni Dokou |
Sustained release delivery of a thrombin inhibitor
|
US20070083240A1
(en)
*
|
2003-05-08 |
2007-04-12 |
Peterson David K L |
Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
|
CA2525647A1
(en)
|
2003-05-16 |
2005-02-24 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US8066639B2
(en)
|
2003-06-10 |
2011-11-29 |
Abbott Diabetes Care Inc. |
Glucose measuring device for use in personal area network
|
US20040253293A1
(en)
*
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
EP2112920B1
(de)
|
2003-06-26 |
2018-07-25 |
Intellipharmaceutics Corp. |
Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten
|
JP2007526019A
(ja)
*
|
2003-07-10 |
2007-09-13 |
アルコン,インコーポレイティド |
眼科用薬物送達デバイス
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US7761130B2
(en)
|
2003-07-25 |
2010-07-20 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US20190357827A1
(en)
|
2003-08-01 |
2019-11-28 |
Dexcom, Inc. |
Analyte sensor
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US7774145B2
(en)
|
2003-08-01 |
2010-08-10 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
MXPA06001548A
(es)
*
|
2003-08-06 |
2006-09-04 |
Johnson & Johnson |
Suministro uniforme de topiramato durante un periodo prolongado con formulaciones de dispersion.
|
US20140121989A1
(en)
|
2003-08-22 |
2014-05-01 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
US8233959B2
(en)
|
2003-08-22 |
2012-07-31 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
EP1701697A2
(de)
*
|
2003-09-02 |
2006-09-20 |
ALZA Corporation |
Neue arzneimittelzusammensetzungen und dosierformen von topiramat
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
WO2005030166A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Oros push-stick for controlled delivery of active agents
|
MXPA06003450A
(es)
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Recubrimiento de farmaco que proporciona alta carga del farmaco y metodos para proporcionar el mismo.
|
US20050158382A1
(en)
*
|
2003-09-26 |
2005-07-21 |
Evangeline Cruz |
Controlled release formulations of opioid and nonopioid analgesics
|
AU2004275813A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Osmotic dosage forms for controlled delivery of alprazolam
|
AU2004275835B2
(en)
|
2003-09-26 |
2011-06-23 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US20050118246A1
(en)
*
|
2003-10-31 |
2005-06-02 |
Wong Patrick S. |
Dosage forms and layered deposition processes for fabricating dosage forms
|
WO2005041925A2
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption
|
US7299082B2
(en)
|
2003-10-31 |
2007-11-20 |
Abbott Diabetes Care, Inc. |
Method of calibrating an analyte-measurement device, and associated methods, devices and systems
|
USD914881S1
(en)
|
2003-11-05 |
2021-03-30 |
Abbott Diabetes Care Inc. |
Analyte sensor electronic mount
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
CN102276732B
(zh)
|
2003-11-28 |
2016-01-20 |
伊士曼化工公司 |
纤维素共聚体和氧化方法
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US8423114B2
(en)
|
2006-10-04 |
2013-04-16 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
DE602004029092D1
(de)
|
2003-12-05 |
2010-10-21 |
Dexcom Inc |
Kalibrationsmethoden für einen kontinuierlich arbeitenden analytsensor
|
WO2005062829A2
(en)
*
|
2003-12-19 |
2005-07-14 |
Advanced Bionics Corporation |
Skull-mounted electrical stimulation system and method for treating patients
|
KR20060123493A
(ko)
*
|
2003-12-23 |
2006-12-01 |
알자 코포레이션 |
제어된 전달을 위한 약물 조성물의 용해도를 증가시키는방법 및 제형
|
EP1701706A2
(de)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Neue arzneimittelzusammensetzungen und dosierformen
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
JP2007517063A
(ja)
*
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
トピラメートの新規な薬剤組成物および剤形
|
BRPI0506983A
(pt)
|
2004-01-20 |
2007-07-03 |
Allergan Inc |
composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US8512738B2
(en)
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050267555A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Marnfeldt Goran N |
Engagement tool for implantable medical devices
|
US20060010098A1
(en)
|
2004-06-04 |
2006-01-12 |
Goodnow Timothy T |
Diabetes care host-client architecture and data management system
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
WO2006010013A1
(en)
*
|
2004-07-09 |
2006-01-26 |
Advanced Bionics Corporation |
Systems and methods for using a butterfly coil to communicate with or transfer power to an implantable medical device
|
WO2006017347A2
(en)
*
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
US7946984B2
(en)
*
|
2004-07-13 |
2011-05-24 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8886272B2
(en)
|
2004-07-13 |
2014-11-11 |
Dexcom, Inc. |
Analyte sensor
|
US20060016700A1
(en)
|
2004-07-13 |
2006-01-26 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8452368B2
(en)
|
2004-07-13 |
2013-05-28 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
WO2006127694A2
(en)
|
2004-07-13 |
2006-11-30 |
Dexcom, Inc. |
Analyte sensor
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US8452407B2
(en)
*
|
2004-08-16 |
2013-05-28 |
Boston Scientific Neuromodulation Corporation |
Methods for treating gastrointestinal disorders
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
EP1789057B1
(de)
*
|
2004-08-30 |
2010-02-24 |
Seo Hong Yoo |
Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
CA2580329C
(en)
|
2004-09-13 |
2015-01-06 |
Chrono Therapeutics Inc. |
Biosynchronous transdermal drug delivery
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
EP1809330B1
(de)
*
|
2004-10-15 |
2011-04-27 |
Seo Hong Yoo |
Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
|
CA2585471A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
US9358393B1
(en)
|
2004-11-09 |
2016-06-07 |
Andres M. Lozano |
Stimulation methods and systems for treating an auditory dysfunction
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US7483746B2
(en)
*
|
2004-12-06 |
2009-01-27 |
Boston Scientific Neuromodulation Corp. |
Stimulation of the stomach in response to sensed parameters to treat obesity
|
US20060161217A1
(en)
*
|
2004-12-21 |
2006-07-20 |
Jaax Kristen N |
Methods and systems for treating obesity
|
US9095713B2
(en)
*
|
2004-12-21 |
2015-08-04 |
Allison M. Foster |
Methods and systems for treating autism by decreasing neural activity within the brain
|
US9327069B2
(en)
|
2004-12-21 |
2016-05-03 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a medical condition by promoting neural remodeling within the brain
|
US20070038264A1
(en)
*
|
2004-12-21 |
2007-02-15 |
Jaax Kristen N |
Methods and systems for treating autism
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US8515541B1
(en)
|
2004-12-22 |
2013-08-20 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating post-stroke disorders
|
US9352145B2
(en)
*
|
2004-12-22 |
2016-05-31 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a psychotic disorder
|
JP2008525109A
(ja)
*
|
2004-12-22 |
2008-07-17 |
アルコン,インコーポレイティド |
点眼剤投与装置
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US8029441B2
(en)
|
2006-02-28 |
2011-10-04 |
Abbott Diabetes Care Inc. |
Analyte sensor transmitter unit configuration for a data monitoring and management system
|
US20090105569A1
(en)
|
2006-04-28 |
2009-04-23 |
Abbott Diabetes Care, Inc. |
Introducer Assembly and Methods of Use
|
US9636450B2
(en)
|
2007-02-19 |
2017-05-02 |
Udo Hoss |
Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
|
US9743862B2
(en)
|
2011-03-31 |
2017-08-29 |
Abbott Diabetes Care Inc. |
Systems and methods for transcutaneously implanting medical devices
|
US7731657B2
(en)
|
2005-08-30 |
2010-06-08 |
Abbott Diabetes Care Inc. |
Analyte sensor introducer and methods of use
|
US10226207B2
(en)
|
2004-12-29 |
2019-03-12 |
Abbott Diabetes Care Inc. |
Sensor inserter having introducer
|
US8512243B2
(en)
|
2005-09-30 |
2013-08-20 |
Abbott Diabetes Care Inc. |
Integrated introducer and transmitter assembly and methods of use
|
US9398882B2
(en)
|
2005-09-30 |
2016-07-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor and data processing device
|
US9572534B2
(en)
|
2010-06-29 |
2017-02-21 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US7883464B2
(en)
|
2005-09-30 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Integrated transmitter unit and sensor introducer mechanism and methods of use
|
US7697967B2
(en)
|
2005-12-28 |
2010-04-13 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
US8571624B2
(en)
|
2004-12-29 |
2013-10-29 |
Abbott Diabetes Care Inc. |
Method and apparatus for mounting a data transmission device in a communication system
|
US9788771B2
(en)
|
2006-10-23 |
2017-10-17 |
Abbott Diabetes Care Inc. |
Variable speed sensor insertion devices and methods of use
|
US8333714B2
(en)
|
2006-09-10 |
2012-12-18 |
Abbott Diabetes Care Inc. |
Method and system for providing an integrated analyte sensor insertion device and data processing unit
|
US9259175B2
(en)
|
2006-10-23 |
2016-02-16 |
Abbott Diabetes Care, Inc. |
Flexible patch for fluid delivery and monitoring body analytes
|
IL166114A0
(en)
*
|
2005-01-03 |
2006-01-15 |
Calcident Active Ltd |
Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
|
WO2006081569A2
(en)
*
|
2005-01-27 |
2006-08-03 |
Alza Corporation |
Oral osmotic dosage form having a high flux membrane
|
EP1685841A1
(de)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
WO2006084083A2
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Devices for delivering agents to a vaginal tract
|
WO2006084082A1
(en)
*
|
2005-02-03 |
2006-08-10 |
Duramed Pharmaceuticals, Inc. |
Compositions of unconjugated estrogens and methods for their use
|
EP1690540A1
(de)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Zusammensetzung enthaltend Ocaperidon
|
US20060185665A1
(en)
*
|
2005-02-22 |
2006-08-24 |
Bachinski Thomas J |
Sauna fireplace
|
US20060194724A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Whitehurst Todd K |
Methods and systems for nerve regeneration
|
US20060204548A1
(en)
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
US7848803B1
(en)
|
2005-03-14 |
2010-12-07 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US7702385B2
(en)
*
|
2005-11-16 |
2010-04-20 |
Boston Scientific Neuromodulation Corporation |
Electrode contact configurations for an implantable stimulator
|
US7853321B2
(en)
*
|
2005-03-14 |
2010-12-14 |
Boston Scientific Neuromodulation Corporation |
Stimulation of a stimulation site within the neck or head
|
US8423155B1
(en)
|
2005-03-14 |
2013-04-16 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
JP2008536928A
(ja)
*
|
2005-04-19 |
2008-09-11 |
アルザ・コーポレーシヨン |
トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
|
US8112240B2
(en)
|
2005-04-29 |
2012-02-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing leak detection in data monitoring and management systems
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
CA2613357A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Alza Corporation |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
DE102005031577A1
(de)
*
|
2005-07-06 |
2007-01-11 |
Bayer Healthcare Ag |
Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
|
US9447781B2
(en)
*
|
2005-07-22 |
2016-09-20 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
EP1909812A4
(de)
|
2005-07-27 |
2009-11-25 |
Univ Florida |
Kleine verbindungen zur korrektur von protein-missfaltungen und verwendungen davon
|
US20070031496A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Edgren David E |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070048347A1
(en)
|
2005-08-26 |
2007-03-01 |
Laura Bardach |
Intra-oral device for treating obesity
|
US20080314395A1
(en)
|
2005-08-31 |
2008-12-25 |
Theuniversity Of Virginia Patent Foundation |
Accuracy of Continuous Glucose Sensors
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US7684858B2
(en)
*
|
2005-09-21 |
2010-03-23 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for placing an implanted stimulator for stimulating tissue
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
EP2664337B1
(de)
|
2005-09-27 |
2019-08-14 |
TissueTech, Inc. |
Amnion-Zubereitungen und gereinigte Zusammensetzungen und Anwendungsverfahren
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US8880138B2
(en)
|
2005-09-30 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Device for channeling fluid and methods of use
|
US9521968B2
(en)
|
2005-09-30 |
2016-12-20 |
Abbott Diabetes Care Inc. |
Analyte sensor retention mechanism and methods of use
|
RU2429236C2
(ru)
|
2005-10-04 |
2011-09-20 |
Байер Шеринг Фарма Акциенгезельшафт |
Новая полиморфная форма и аморфная форма 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолинил)-фенил]-1, 3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
WO2007044234A1
(en)
*
|
2005-10-07 |
2007-04-19 |
Alza Corporation |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US7766829B2
(en)
|
2005-11-04 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and system for providing basal profile modification in analyte monitoring and management systems
|
JP2009517343A
(ja)
|
2005-11-14 |
2009-04-30 |
エンタープライズ パートナーズ ベンチャー キャピタル |
組織損傷のための幹細胞因子療法
|
US8022054B2
(en)
|
2005-11-28 |
2011-09-20 |
Marinus Pharmaceuticals |
Liquid ganaxolone formulations and methods for the making and use thereof
|
JP5180834B2
(ja)
|
2005-11-29 |
2013-04-10 |
スミスクライン ビーチャム コーポレーション |
治療方法
|
US7729758B2
(en)
*
|
2005-11-30 |
2010-06-01 |
Boston Scientific Neuromodulation Corporation |
Magnetically coupled microstimulators
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US11298058B2
(en)
|
2005-12-28 |
2022-04-12 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
EP1968432A4
(de)
|
2005-12-28 |
2009-10-21 |
Abbott Diabetes Care Inc |
Einführung eines medizinischen gerätes
|
US7610100B2
(en)
*
|
2005-12-30 |
2009-10-27 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating osteoarthritis
|
US7835803B1
(en)
|
2006-01-17 |
2010-11-16 |
Boston Scientific Neuromodulation Corporation |
Lead assemblies with one or more switching networks
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US7736310B2
(en)
|
2006-01-30 |
2010-06-15 |
Abbott Diabetes Care Inc. |
On-body medical device securement
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
US7885698B2
(en)
|
2006-02-28 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Method and system for providing continuous calibration of implantable analyte sensors
|
US7826879B2
(en)
|
2006-02-28 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Analyte sensors and methods of use
|
US8309104B2
(en)
*
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
US8175710B2
(en)
*
|
2006-03-14 |
2012-05-08 |
Boston Scientific Neuromodulation Corporation |
Stimulator system with electrode array and the method of making the same
|
US7777641B2
(en)
*
|
2006-03-29 |
2010-08-17 |
Advanced Bionics, Llc |
Systems and methods of facilitating communication between a first and second device
|
US8473022B2
(en)
|
2008-01-31 |
2013-06-25 |
Abbott Diabetes Care Inc. |
Analyte sensor with time lag compensation
|
US8140312B2
(en)
|
2007-05-14 |
2012-03-20 |
Abbott Diabetes Care Inc. |
Method and system for determining analyte levels
|
US9392969B2
(en)
|
2008-08-31 |
2016-07-19 |
Abbott Diabetes Care Inc. |
Closed loop control and signal attenuation detection
|
US8346335B2
(en)
|
2008-03-28 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US8374668B1
(en)
|
2007-10-23 |
2013-02-12 |
Abbott Diabetes Care Inc. |
Analyte sensor with lag compensation
|
US7620438B2
(en)
|
2006-03-31 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for powering an electronic device
|
US7618369B2
(en)
|
2006-10-02 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for dynamically updating calibration parameters for an analyte sensor
|
US8219173B2
(en)
|
2008-09-30 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Optimizing analyte sensor calibration
|
US7630748B2
(en)
|
2006-10-25 |
2009-12-08 |
Abbott Diabetes Care Inc. |
Method and system for providing analyte monitoring
|
US7653425B2
(en)
|
2006-08-09 |
2010-01-26 |
Abbott Diabetes Care Inc. |
Method and system for providing calibration of an analyte sensor in an analyte monitoring system
|
US9675290B2
(en)
|
2012-10-30 |
2017-06-13 |
Abbott Diabetes Care Inc. |
Sensitivity calibration of in vivo sensors used to measure analyte concentration
|
US8226891B2
(en)
|
2006-03-31 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods therefor
|
US8224415B2
(en)
|
2009-01-29 |
2012-07-17 |
Abbott Diabetes Care Inc. |
Method and device for providing offset model based calibration for analyte sensor
|
US7801582B2
(en)
|
2006-03-31 |
2010-09-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management system and methods therefor
|
CN101453993A
(zh)
*
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
ATE537826T1
(de)
|
2006-05-16 |
2012-01-15 |
Knopp Neurosciences Inc |
Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
|
WO2007143225A2
(en)
|
2006-06-07 |
2007-12-13 |
Abbott Diabetes Care, Inc. |
Analyte monitoring system and method
|
PL2526932T3
(pl)
|
2006-06-19 |
2017-12-29 |
Alpharma Pharmaceuticals Llc |
Kompozycja farmaceutyczna
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8504163B1
(en)
|
2006-06-30 |
2013-08-06 |
Boston Scientific Neuromodulation Corporation |
Cranially mounted stimulation systems and methods
|
US8401654B1
(en)
|
2006-06-30 |
2013-03-19 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating one or more effects of deafferentation
|
CN101528830A
(zh)
|
2006-07-10 |
2009-09-09 |
麦德医像公司 |
超弹性环氧水凝胶
|
EP2056818B1
(de)
|
2006-08-11 |
2011-05-25 |
The Johns Hopkins University |
Zusammensetzungen und verfahren für nervenschutz
|
EP2054076A2
(de)
*
|
2006-08-21 |
2009-05-06 |
United Therapeutics Corporation |
Kombinationstherapie zur behandlung von virusinfektionen
|
HUE028086T2
(en)
|
2006-09-22 |
2016-11-28 |
Pharmacyclics Llc |
Bruton tyrosine kinase inhibitors
|
US7445528B1
(en)
|
2006-09-29 |
2008-11-04 |
Boston Scientific Neuromodulation Corporation |
Connector assemblies
|
EP2106238A4
(de)
|
2006-10-26 |
2011-03-09 |
Abbott Diabetes Care Inc |
Verfahren, system und computerprogrammprodukt zur echtzeit-erkennung eines empfindlichkeitsabfalls in analytsensoren
|
US7347746B1
(en)
|
2006-10-27 |
2008-03-25 |
Boston Scientific Neuromodulation Corporation |
Receptacle connector assembly
|
DE102006051625A1
(de)
*
|
2006-11-02 |
2008-05-08 |
Bayer Materialscience Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
WO2008070479A2
(en)
|
2006-12-01 |
2008-06-12 |
Allergan, Inc. |
Method for determining optimum intraocular locations for drug delivery systems
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US8846073B2
(en)
*
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
WO2008084698A1
(ja)
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
タクロリムス徐放性医薬組成物
|
US20080176955A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Victory Pharma, Inc. |
Combined administration of benzonatate and guaifenesin
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US8121857B2
(en)
|
2007-02-15 |
2012-02-21 |
Abbott Diabetes Care Inc. |
Device and method for automatic data acquisition and/or detection
|
US20080199894A1
(en)
|
2007-02-15 |
2008-08-21 |
Abbott Diabetes Care, Inc. |
Device and method for automatic data acquisition and/or detection
|
US8732188B2
(en)
|
2007-02-18 |
2014-05-20 |
Abbott Diabetes Care Inc. |
Method and system for providing contextual based medication dosage determination
|
US8930203B2
(en)
|
2007-02-18 |
2015-01-06 |
Abbott Diabetes Care Inc. |
Multi-function analyte test device and methods therefor
|
US8123686B2
(en)
|
2007-03-01 |
2012-02-28 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing rolling data in communication systems
|
US8519148B2
(en)
*
|
2007-03-14 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
CA2683959C
(en)
|
2007-04-14 |
2017-08-29 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
EP2146625B1
(de)
|
2007-04-14 |
2019-08-14 |
Abbott Diabetes Care Inc. |
Verfahren und gerät zur bereitstellung von datenverarbeitung und kontrolle in einem medizinischen kommunikationssystem
|
CA2683953C
(en)
|
2007-04-14 |
2016-08-02 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
CA2683721C
(en)
|
2007-04-14 |
2017-05-23 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
|
WO2008128210A1
(en)
|
2007-04-14 |
2008-10-23 |
Abbott Diabetes Care, Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
ES2817503T3
(es)
|
2007-04-14 |
2021-04-07 |
Abbott Diabetes Care Inc |
Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
US8461985B2
(en)
|
2007-05-08 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8456301B2
(en)
|
2007-05-08 |
2013-06-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US7928850B2
(en)
|
2007-05-08 |
2011-04-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8665091B2
(en)
|
2007-05-08 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Method and device for determining elapsed sensor life
|
US8260558B2
(en)
|
2007-05-14 |
2012-09-04 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8239166B2
(en)
|
2007-05-14 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US10002233B2
(en)
|
2007-05-14 |
2018-06-19 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8103471B2
(en)
|
2007-05-14 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8560038B2
(en)
|
2007-05-14 |
2013-10-15 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8444560B2
(en)
|
2007-05-14 |
2013-05-21 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US9125548B2
(en)
|
2007-05-14 |
2015-09-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US7996158B2
(en)
|
2007-05-14 |
2011-08-09 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8600681B2
(en)
|
2007-05-14 |
2013-12-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US20200037874A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2008150917A1
(en)
|
2007-05-31 |
2008-12-11 |
Abbott Diabetes Care, Inc. |
Insertion devices and methods
|
WO2008154312A1
(en)
|
2007-06-08 |
2008-12-18 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
JP5680960B2
(ja)
|
2007-06-21 |
2015-03-04 |
アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. |
健康管理装置および方法
|
US8617069B2
(en)
|
2007-06-21 |
2013-12-31 |
Abbott Diabetes Care Inc. |
Health monitor
|
US8160900B2
(en)
|
2007-06-29 |
2012-04-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
|
US8834366B2
(en)
|
2007-07-31 |
2014-09-16 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor calibration
|
US7768386B2
(en)
|
2007-07-31 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
US8263641B2
(en)
|
2007-09-10 |
2012-09-11 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20090088681A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Mcintyre Jon T |
Device and method for the treatment of intra-abdominal disease
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
US9452258B2
(en)
|
2007-10-09 |
2016-09-27 |
Dexcom, Inc. |
Integrated insulin delivery system with continuous glucose sensor
|
US8377031B2
(en)
|
2007-10-23 |
2013-02-19 |
Abbott Diabetes Care Inc. |
Closed loop control system with safety parameters and methods
|
US8409093B2
(en)
|
2007-10-23 |
2013-04-02 |
Abbott Diabetes Care Inc. |
Assessing measures of glycemic variability
|
US8216138B1
(en)
|
2007-10-23 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
|
WO2009073734A2
(en)
*
|
2007-12-03 |
2009-06-11 |
Medipacs, Inc. |
Fluid metering device
|
CA2706658A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20090164239A1
(en)
|
2007-12-19 |
2009-06-25 |
Abbott Diabetes Care, Inc. |
Dynamic Display Of Glucose Information
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
BRPI0908114A2
(pt)
*
|
2008-02-15 |
2015-10-06 |
Sun Pharma Advanced Res Co Ltd |
tabuleta oral de liberação controlada
|
US8252229B2
(en)
|
2008-04-10 |
2012-08-28 |
Abbott Diabetes Care Inc. |
Method and system for sterilizing an analyte sensor
|
US8591410B2
(en)
|
2008-05-30 |
2013-11-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US8924159B2
(en)
|
2008-05-30 |
2014-12-30 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US7826382B2
(en)
|
2008-05-30 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Close proximity communication device and methods
|
WO2010009172A1
(en)
|
2008-07-14 |
2010-01-21 |
Abbott Diabetes Care Inc. |
Closed loop control system interface and methods
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
WO2010027875A2
(en)
|
2008-08-27 |
2010-03-11 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
US20100057040A1
(en)
|
2008-08-31 |
2010-03-04 |
Abbott Diabetes Care, Inc. |
Robust Closed Loop Control And Methods
|
US8734422B2
(en)
|
2008-08-31 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Closed loop control with improved alarm functions
|
US8622988B2
(en)
|
2008-08-31 |
2014-01-07 |
Abbott Diabetes Care Inc. |
Variable rate closed loop control and methods
|
US9943644B2
(en)
|
2008-08-31 |
2018-04-17 |
Abbott Diabetes Care Inc. |
Closed loop control with reference measurement and methods thereof
|
US8986208B2
(en)
|
2008-09-30 |
2015-03-24 |
Abbott Diabetes Care Inc. |
Analyte sensor sensitivity attenuation mitigation
|
EP3025727A1
(de)
|
2008-10-02 |
2016-06-01 |
The J. David Gladstone Institutes |
Verfahren zur behandlung von lebererkrankungen
|
US20100104654A1
(en)
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US9326707B2
(en)
|
2008-11-10 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Alarm characterization for analyte monitoring devices and systems
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
DE102008059206A1
(de)
|
2008-11-27 |
2010-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
|
US8103456B2
(en)
|
2009-01-29 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and device for early signal attenuation detection using blood glucose measurements
|
CA2757037C
(en)
|
2009-01-29 |
2019-08-06 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US9402544B2
(en)
|
2009-02-03 |
2016-08-02 |
Abbott Diabetes Care Inc. |
Analyte sensor and apparatus for insertion of the sensor
|
US20100204325A1
(en)
*
|
2009-02-11 |
2010-08-12 |
Allergan, Inc. |
Valproic acid drug delivery systems and intraocular therapeutic uses thereof
|
JP2012520884A
(ja)
|
2009-03-18 |
2012-09-10 |
ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー |
フラビウイルス科ウイルス感染症を治療する方法および組成物
|
US8497777B2
(en)
|
2009-04-15 |
2013-07-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring system having an alert
|
WO2010121229A1
(en)
|
2009-04-16 |
2010-10-21 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
EP2421901B1
(de)
|
2009-04-24 |
2015-10-28 |
Tissue Tech, Inc. |
Zusammensetzungen mit hc-ha-komplex und verfahren zu ihrer verwendung
|
US9226701B2
(en)
|
2009-04-28 |
2016-01-05 |
Abbott Diabetes Care Inc. |
Error detection in critical repeating data in a wireless sensor system
|
US8483967B2
(en)
|
2009-04-29 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Method and system for providing real time analyte sensor calibration with retrospective backfill
|
EP2424426B1
(de)
|
2009-04-29 |
2020-01-08 |
Abbott Diabetes Care, Inc. |
Verfahren und system zur datenübertragung in einem system für kontinuierliche glucoseüberwachung und glucosemanagement
|
US20100278897A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Intraocular bioactive agent delivery system with molecular partitioning system
|
US8632511B2
(en)
*
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
US9184490B2
(en)
|
2009-05-29 |
2015-11-10 |
Abbott Diabetes Care Inc. |
Medical device antenna systems having external antenna configurations
|
BRPI0925100A2
(pt)
|
2009-06-02 |
2016-07-19 |
Dow Global Technologies Llc |
forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
CN102802418A
(zh)
*
|
2009-06-19 |
2012-11-28 |
诺普神经科学股份有限公司 |
用于治疗肌萎缩性侧索硬化的组合物和方法
|
US8613892B2
(en)
|
2009-06-30 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Analyte meter with a moveable head and methods of using the same
|
DK3689237T3
(da)
|
2009-07-23 |
2021-08-16 |
Abbott Diabetes Care Inc |
Fremgangsmåde til fremstilling og system til kontinuerlig analytmåling
|
WO2011014851A1
(en)
|
2009-07-31 |
2011-02-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte monitoring system calibration accuracy
|
JP5641483B2
(ja)
|
2009-08-18 |
2014-12-17 |
国立大学法人東北大学 |
持続性ドラッグデリバリーシステム
|
US9314195B2
(en)
|
2009-08-31 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Analyte signal processing device and methods
|
ES2912584T3
(es)
|
2009-08-31 |
2022-05-26 |
Abbott Diabetes Care Inc |
Un sistema y procedimiento de monitorización de glucosa
|
EP3923295A1
(de)
|
2009-08-31 |
2021-12-15 |
Abbott Diabetes Care, Inc. |
Medizinische vorrichtungen und verfahren
|
WO2011026148A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods for managing power and noise
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
DE102009042855A1
(de)
*
|
2009-09-24 |
2011-03-31 |
Pfenning Elektroanlagen Gmbh |
Portalhubwagen zum Einsatz in Containerterminals und für allgemeine Transportaufgaben
|
WO2011041469A1
(en)
|
2009-09-29 |
2011-04-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing notification function in analyte monitoring systems
|
WO2011041531A1
(en)
|
2009-09-30 |
2011-04-07 |
Abbott Diabetes Care Inc. |
Interconnect for on-body analyte monitoring device
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
WO2011053881A1
(en)
|
2009-10-30 |
2011-05-05 |
Abbott Diabetes Care Inc. |
Method and apparatus for detecting false hypoglycemic conditions
|
EP2498783B1
(de)
|
2009-11-09 |
2018-08-22 |
Allergan, Inc. |
Zusammensetzungen und verfahren zur stimulation des haarwuchses
|
WO2011075481A1
(en)
|
2009-12-16 |
2011-06-23 |
Allergan, Inc. |
Intracameral devices for sustained delivery
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
US20110172645A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Wearable drug delivery device including integrated pumping and activation elements
|
US20110172637A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Drug delivery device including tissue support structure
|
US20110172609A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
US20110172639A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Device and method for delivery of microneedle to desired depth within the skin
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
USD924406S1
(en)
|
2010-02-01 |
2021-07-06 |
Abbott Diabetes Care Inc. |
Analyte sensor inserter
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
WO2011112753A1
(en)
|
2010-03-10 |
2011-09-15 |
Abbott Diabetes Care Inc. |
Systems, devices and methods for managing glucose levels
|
ES2881798T3
(es)
|
2010-03-24 |
2021-11-30 |
Abbott Diabetes Care Inc |
Insertadores de dispositivos médicos y procedimientos de inserción y uso de dispositivos médicos
|
TR201802207T4
(tr)
|
2010-03-29 |
2018-03-21 |
Astellas Pharma Inc |
Kontrollü Salımlı Farmasötik Bileşim.
|
EP2558866B1
(de)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potenzierung einer antikrebs-wirkung durch eine kombinationstherapie mit ber-pfad-hemmern
|
WO2011139489A2
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
JP2013525448A
(ja)
|
2010-04-27 |
2013-06-20 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
CA2800913C
(en)
|
2010-06-03 |
2019-07-23 |
Pharmacyclics, Inc. |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
US8635046B2
(en)
|
2010-06-23 |
2014-01-21 |
Abbott Diabetes Care Inc. |
Method and system for evaluating analyte sensor response characteristics
|
US10092229B2
(en)
|
2010-06-29 |
2018-10-09 |
Abbott Diabetes Care Inc. |
Calibration of analyte measurement system
|
US11064921B2
(en)
|
2010-06-29 |
2021-07-20 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
RS61601B1
(sr)
|
2010-08-05 |
2021-04-29 |
Forsight Vision4 Inc |
Aparati za ubrizgavanje za dostavu leka
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
RS62540B1
(sr)
|
2010-08-05 |
2021-12-31 |
Forsight Vision4 Inc |
Aparat za lečenje oka
|
AU2011293201B2
(en)
|
2010-08-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
US11213226B2
(en)
|
2010-10-07 |
2022-01-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US8518440B2
(en)
|
2010-12-21 |
2013-08-27 |
Confluent Surgical, Inc. |
Biodegradable osmotic pump implant for drug delivery
|
RU2017124629A
(ru)
|
2011-01-20 |
2019-01-30 |
Бионевиа Фармасьютикалс Инк. |
Композиции с модифицированным высвобождением эпалрестата или его производных и способы их использования
|
US8801768B2
(en)
*
|
2011-01-21 |
2014-08-12 |
Endologix, Inc. |
Graft systems having semi-permeable filling structures and methods for their use
|
US10136845B2
(en)
|
2011-02-28 |
2018-11-27 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
CN103619255B
(zh)
|
2011-02-28 |
2016-11-02 |
雅培糖尿病护理公司 |
与分析物监测装置关联的装置、系统和方法以及结合了它们的装置
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
DK3575796T3
(da)
|
2011-04-15 |
2021-01-18 |
Dexcom Inc |
Avanceret analytsensorkalibrering og fejldetektion
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2012175698A1
(en)
|
2011-06-23 |
2012-12-27 |
Université Libre de Bruxelles |
Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
|
EP2726016B1
(de)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
WO2013006643A1
(en)
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
EP3222720A1
(de)
|
2011-09-01 |
2017-09-27 |
University of Southern California |
Verfahren zur herstellung von hochdurchsatzpeptidomimetika, oral bioverfügbaren wirkstoffen und zusammensetzungen damit
|
CN103917231B
(zh)
|
2011-09-13 |
2016-09-28 |
药品循环有限责任公司 |
组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途
|
WO2013040247A2
(en)
|
2011-09-16 |
2013-03-21 |
Forsight Vision4, Inc. |
Fluid exchange apparatus and methods
|
AU2012325341B2
(en)
|
2011-10-19 |
2017-01-05 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
WO2013066873A1
(en)
|
2011-10-31 |
2013-05-10 |
Abbott Diabetes Care Inc. |
Electronic devices having integrated reset systems and methods thereof
|
WO2013066849A1
(en)
|
2011-10-31 |
2013-05-10 |
Abbott Diabetes Care Inc. |
Model based variable risk false glucose threshold alarm prevention mechanism
|
US9980669B2
(en)
|
2011-11-07 |
2018-05-29 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9317656B2
(en)
|
2011-11-23 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US8710993B2
(en)
|
2011-11-23 |
2014-04-29 |
Abbott Diabetes Care Inc. |
Mitigating single point failure of devices in an analyte monitoring system and methods thereof
|
WO2013078426A2
(en)
|
2011-11-25 |
2013-05-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods of use
|
JP6126118B2
(ja)
|
2011-11-30 |
2017-05-10 |
ビカム ファーマスーティカルス,インコーポレイテッド |
オプシン結合性リガンド、組成物、及び使用方法
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
AU2012347785B2
(en)
|
2011-12-06 |
2017-03-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for treating viral diseases
|
FI3300658T3
(fi)
|
2011-12-11 |
2024-03-01 |
Abbott Diabetes Care Inc |
Analyyttianturimenetelmiä
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
MY168791A
(en)
|
2012-01-06 |
2018-12-04 |
Abide Therapeutics Inc |
Carbamate compounds and of making and using same
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
KR20140123571A
(ko)
|
2012-02-16 |
2014-10-22 |
에이티와이알 파마, 인코포레이티드 |
자가면역 및 염증성 질환의 치료를 위한 히스티딜trna 신테타제
|
CA2906274A1
(en)
|
2012-03-14 |
2013-09-19 |
Medipacs, Inc. |
Smart polymer materials with excess reactive molecules
|
KR20150007297A
(ko)
|
2012-05-07 |
2015-01-20 |
바이엘 파마 악티엔게젤샤프트 |
니페디핀 및 칸데사르탄 실렉세틸을 포함하는 제약 투여 형태의 제조 방법
|
CN110354132A
(zh)
|
2012-06-04 |
2019-10-22 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶抑制剂的晶形
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
UY34856A
(es)
|
2012-07-03 |
2013-12-31 |
Bayer Pharma AG |
Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
|
JP2015528001A
(ja)
|
2012-07-11 |
2015-09-24 |
ティッシュテック,インク. |
Hc−ha/ptx3複合体を含む組成物およびその使用方法
|
EP3395252A1
(de)
|
2012-08-30 |
2018-10-31 |
Abbott Diabetes Care, Inc. |
Ausfallerkennung bei kontinuierlichen analytüberwachungsdaten bei datenabweichungen
|
US9968306B2
(en)
|
2012-09-17 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
|
US9907492B2
(en)
|
2012-09-26 |
2018-03-06 |
Abbott Diabetes Care Inc. |
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
|
DK2900674T3
(en)
|
2012-09-28 |
2017-07-03 |
Univ Washington Through Its Center For Commercialization |
RELATIONSHIPS AND PROCEDURES FOR PREVENTION, TREATMENT AND / OR PROTECTION AGAINST SENSITIVE CELL DEATH
|
US9717741B2
(en)
|
2012-10-11 |
2017-08-01 |
Anaplasi Pharmaceuticals Llc |
Method and compositions for treating psoriasis
|
JP6059352B2
(ja)
|
2012-10-11 |
2017-01-11 |
アナプラシ ファーマシューティカルズ エルエルシー |
乾癬を治療するための方法及び組成物
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
GB2510826B
(en)
|
2013-02-13 |
2015-09-02 |
Animax Ltd |
Improvements in or relating to release of a beneficial substance from a bolus
|
CA2901280A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
CA2905496A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
WO2014152034A1
(en)
|
2013-03-15 |
2014-09-25 |
Abbott Diabetes Care Inc. |
Sensor fault detection using analyte sensor data pattern comparison
|
CN105120659A
(zh)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
用于降低溶解可变性的具有流变改性剂的组合物
|
US9474475B1
(en)
|
2013-03-15 |
2016-10-25 |
Abbott Diabetes Care Inc. |
Multi-rate analyte sensor data collection with sample rate configurable signal processing
|
US10433773B1
(en)
|
2013-03-15 |
2019-10-08 |
Abbott Diabetes Care Inc. |
Noise rejection methods and apparatus for sparsely sampled analyte sensor data
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
LT3019167T
(lt)
|
2013-07-12 |
2021-03-25 |
Knopp Biosciences Llc |
Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
WO2015023786A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
PL3033081T3
(pl)
|
2013-08-13 |
2021-08-30 |
Knopp Biosciences Llc |
Kompozycje i sposoby do leczenia przewlekłej pokrzywki
|
WO2015054283A1
(en)
|
2013-10-08 |
2015-04-16 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
CA2933166C
(en)
|
2013-12-31 |
2020-10-27 |
Abbott Diabetes Care Inc. |
Self-powered analyte sensor and devices using the same
|
EP4151150A1
(de)
|
2014-03-30 |
2023-03-22 |
Abbott Diabetes Care, Inc. |
Verfahren und gerät zum bestimmen von mahlzeitenbeginn und peak-ereignissen in analytischen überwachungssystemen
|
EP3134418A4
(de)
|
2014-04-23 |
2018-01-03 |
The Research Foundation for The State University of New York |
Schnelle und effiziente reaktion zur bioorthogonalen reaktion und borhaltige, zusammen damit nützliche heterocyclen
|
MX2016014281A
(es)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
WO2016011191A1
(en)
|
2014-07-15 |
2016-01-21 |
Forsight Vision4, Inc. |
Ocular implant delivery device and method
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
WO2016016770A1
(en)
|
2014-07-26 |
2016-02-04 |
Wockhardt Limited |
A novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof
|
SG11201700943TA
(en)
|
2014-08-08 |
2017-03-30 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
CA2967330A1
(en)
|
2014-11-10 |
2016-05-19 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
AU2016211330A1
(en)
|
2015-01-28 |
2017-08-03 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
EP3253766B1
(de)
|
2015-02-06 |
2019-09-04 |
University of Washington |
Verbindungen und verfahren zur vorbeugung oder behandlung von sensorischem haarzelltod
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
US9579289B2
(en)
|
2015-02-20 |
2017-02-28 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release dosage form
|
US20160243288A1
(en)
|
2015-02-23 |
2016-08-25 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
CA2977521C
(en)
|
2015-02-27 |
2024-03-19 |
Curtana Pharmaceuticals, Inc. |
1-(aryl)-3-(heteroaryl) urea compounds and their use as olig2 inhibitors
|
AU2016226279B2
(en)
|
2015-03-03 |
2021-11-11 |
Pharmacyclics Llc |
Pharmaceutical formulations of Bruton's tyrosine kinase inhibtor
|
JP2018511127A
(ja)
|
2015-03-12 |
2018-04-19 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
渇望入力及び支援システム
|
MA41827A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
|
MA41828A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
|
US10575976B2
(en)
|
2015-04-30 |
2020-03-03 |
Dynamic Mouth Devices, L.L.C. |
Method and apparatus for weight management utilizing an intra-oral device
|
MX2017014344A
(es)
|
2015-05-11 |
2018-04-11 |
Abide Therapeutics Inc |
Metodos para el tratamiento de la inflacion o el dolor neuropatico.
|
US10213139B2
(en)
|
2015-05-14 |
2019-02-26 |
Abbott Diabetes Care Inc. |
Systems, devices, and methods for assembling an applicator and sensor control device
|
WO2016183493A1
(en)
|
2015-05-14 |
2016-11-17 |
Abbott Diabetes Care Inc. |
Compact medical device inserters and related systems and methods
|
CN107847526A
(zh)
|
2015-05-20 |
2018-03-27 |
组织技术公司 |
用于预防上皮细胞的增殖和上皮‑间充质转换的组合物和方法
|
WO2017011346A1
(en)
|
2015-07-10 |
2017-01-19 |
Abbott Diabetes Care Inc. |
System, device and method of dynamic glucose profile response to physiological parameters
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
CA2993009A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
US20170209462A1
(en)
|
2015-08-31 |
2017-07-27 |
Pharmacyclics Llc |
Btk inhibitor combinations for treating multiple myeloma
|
EP3365027B1
(de)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu-spezifische antikörper und deren verwendeng zur hemmung von biofilm
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
JP2019505498A
(ja)
|
2015-12-16 |
2019-02-28 |
ザ・ウォルター・アンド・エリザ・ホール・インスティテュート・オブ・メディカル・リサーチ |
Nk細胞におけるサイトカイン誘導性sh2タンパク質の阻害
|
WO2017125424A1
(en)
|
2016-01-19 |
2017-07-27 |
Janssen Pharmaceutica Nv |
Formulations/compositions comprising a btk inhibitor
|
MA43649A
(fr)
|
2016-01-19 |
2018-11-28 |
Janssen Pharmaceutica Nv |
Formulations/compositions comprenant un inhibiteur de btk
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
CN116509869A
(zh)
|
2016-04-04 |
2023-08-01 |
希诺皮亚生物科学公司 |
使用曲匹地尔治疗锥体外系综合征
|
ES2837524T3
(es)
|
2016-04-05 |
2021-06-30 |
Forsight Vision4 Inc |
Dispositivos de administración de fármacos oculares implantables
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
JP2019516773A
(ja)
|
2016-05-25 |
2019-06-20 |
コンセントリック アナルジジックス,インク. |
改善された局所麻酔のための局所麻酔薬及び血管収縮薬と組み合わせたフェノールtrpv1アゴニストのプロドラッグ
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
EP3957629B1
(de)
|
2016-07-18 |
2023-09-06 |
Arthrosi Therapeutics, Inc. |
Verfahren zur herstellung von deuteriertem hydroxy-benzbromaron und deren zwischenprodukten
|
JP7028860B2
(ja)
|
2016-08-26 |
2022-03-02 |
カーテナ ファーマシューティカルズ,インク. |
Olig2活性の阻害
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
WO2018093950A1
(en)
|
2016-11-16 |
2018-05-24 |
Abide Therapeutics, Inc. |
Pharmaceutical formulations
|
PE20191239A1
(es)
|
2016-11-16 |
2019-09-16 |
Abide Therapeutics Inc |
Formas cristalinas de un inhibidor de magl
|
CA3049105A1
(en)
|
2017-01-04 |
2018-07-12 |
Lauren O. Bakaletz |
Dnabii vaccines and antibodies with enhanced activity
|
AU2018206560A1
(en)
|
2017-01-04 |
2019-07-18 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
JP2020503950A
(ja)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. |
経皮薬剤送達の装置及び方法
|
CN110461217B
(zh)
|
2017-01-23 |
2022-09-16 |
雅培糖尿病护理公司 |
用于分析物传感器插入的系统、装置和方法
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
US11596330B2
(en)
|
2017-03-21 |
2023-03-07 |
Abbott Diabetes Care Inc. |
Methods, devices and system for providing diabetic condition diagnosis and therapy
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
EP3675865A4
(de)
|
2017-09-01 |
2021-06-02 |
University of Washington |
Kristalline formen von verbindungen zur vorbeugung oder behandlung von sensorischem haarzelltod
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US20190120785A1
(en)
|
2017-10-24 |
2019-04-25 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
KR20200123181A
(ko)
|
2018-02-16 |
2020-10-28 |
에스페리온 테라피유틱스 인코포레이티드 |
뱀페도익산의 지속 방출형 제제
|
EP3760191A4
(de)
|
2018-02-28 |
2021-05-05 |
Shanghai WD Pharmaceutical Co., Ltd |
Pharmazeutische zusammensetzung, herstellungsverfahren dafür sowie verwendung davon
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
DK3735228T3
(da)
|
2018-03-05 |
2022-03-14 |
Amneal Complex Products Res Llc |
Programmerbar farmaceutiske sammensætninger til krono-lægemiddelfrigivelse
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
WO2019223753A1
(zh)
|
2018-05-23 |
2019-11-28 |
上海汉都医药科技有限公司 |
活性药物成分的控释系统及其制备方法
|
AU2019279884A1
(en)
|
2018-05-29 |
2020-12-10 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
JP2021531297A
(ja)
|
2018-07-24 |
2021-11-18 |
バイエル・アクチエンゲゼルシヤフト |
経口投与可能であり、修飾された放出を有する薬学的投薬形態
|
JOP20210019A1
(ar)
|
2018-07-24 |
2021-01-24 |
Bayer Ag |
شكل جرعة صيدلانية تعطى عن طريق الفم ذات اطلاق مُعدّل
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
EP3830078A4
(de)
|
2018-07-27 |
2022-03-30 |
Concentric Analgesics, Inc. |
Pegylierte prodrugs von phenolischen trpv1-agonisten
|
SG11202106304RA
(en)
|
2018-12-31 |
2021-07-29 |
Biomea Fusion Llc |
Irreversible inhibitors of menin-mll interaction
|
US20220265630A1
(en)
|
2019-03-15 |
2022-08-25 |
Unicycive Therapeutics Inc. |
Nicorandil derivatives
|
USD1002852S1
(en)
|
2019-06-06 |
2023-10-24 |
Abbott Diabetes Care Inc. |
Analyte sensor device
|
EP3750528A1
(de)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Zusammensetzungen zur behandlung von dystrophien und myotonie
|
CA3145385A1
(en)
|
2019-07-08 |
2021-01-14 |
Steven D. Goodman |
Antibody compositions for disrupting biofilms
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
CN115427403A
(zh)
|
2020-04-21 |
2022-12-02 |
H.隆德贝克有限公司 |
单酰基甘油脂肪酶抑制剂的合成
|
KR102638424B1
(ko)
|
2020-06-10 |
2024-02-19 |
오스펙스 파마슈티칼스, 인코포레이티드 |
듀테트라베나진을 포함하는 삼투성 제형 및 이의 사용 방법
|
WO2022133064A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
USD999913S1
(en)
|
2020-12-21 |
2023-09-26 |
Abbott Diabetes Care Inc |
Analyte sensor inserter
|
WO2022150525A1
(en)
|
2021-01-06 |
2022-07-14 |
Awakn Life Sciences |
Mdma in the treatment of alcohol use disorder
|
EP4337316A1
(de)
|
2021-05-11 |
2024-03-20 |
Awakn Ls Europe Holdings Limited |
Therapeutische aminoindanverbindungen und zusammensetzungen
|
CN115400092A
(zh)
*
|
2021-05-28 |
2022-11-29 |
上海博志研新药物技术有限公司 |
硝苯地平美托洛尔缓释组合物、其制备方法及应用
|
EP4346788A2
(de)
|
2021-06-03 |
2024-04-10 |
Arcadia Medicine, Inc. |
Enantiomere entactogenzusammensetzungen und verfahren zu deren verwendung
|
CA3228627A1
(en)
|
2021-08-11 |
2023-02-16 |
Thomas Butler |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
WO2023022912A1
(en)
|
2021-08-20 |
2023-02-23 |
Biomea Fusion, Inc. |
Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
TW202340177A
(zh)
|
2021-12-30 |
2023-10-16 |
美商拜歐米富士恩股份有限公司 |
作為 flt3抑制劑之吡嗪化合物
|
WO2023139163A1
(en)
|
2022-01-19 |
2023-07-27 |
Awakn Ls Europe Holdings Limited |
1,3-benzodioxole esters and their therapeutic use
|
CN115490316B
(zh)
*
|
2022-01-24 |
2023-09-12 |
成都理工大学 |
一种可再利用的地下水营养物质缓释胶囊体
|
WO2023156565A1
(en)
|
2022-02-16 |
2023-08-24 |
Awakn Ls Europe Holdings Limited |
Bridged ring compounds and their therapeutic use as cns agents
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
WO2023240186A1
(en)
|
2022-06-08 |
2023-12-14 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|
US20240010649A1
(en)
|
2022-07-06 |
2024-01-11 |
Oppilan Pharma Limited |
Crystalline forms of an s1p receptor modulator
|
US11931224B1
(en)
*
|
2022-12-19 |
2024-03-19 |
Robert Parker |
Tooth pod
|